PVG Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

PVG Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,022	Closed	-$415K	–	51
2024 Q2	$415K	Buy	+3,022	New	+$403K	1.64%	17
2018 Q2	–	Sell	-12,040	Closed	-$1.29M	–	99
2018 Q1	$1.29M	Buy	12,040 +1,790	+17%	+$198K	0.72%	41
2017 Q4	$1.09M	Buy	+10,250	New	+$1.1M	0.5%	53
2017 Q1	–	Sell	-6,930	Closed	-$613K	–	95
2016 Q4	$613K	Sell	6,930 -45	-0.6%	-$4.1K	0.26%	64
2016 Q3	$673K	Sell	6,975 -390	-5%	-$37.1K	0.28%	66
2016 Q2	$632K	Sell	7,365 -240	-3%	-$21.5K	0.26%	61
2016 Q1	$661K	Sell	7,605 -150	-2%	-$13.4K	0.26%	54
2015 Q4	$875K	Sell	7,755 -570	-7%	-$61.9K	0.35%	53
2015 Q3	$842K	Buy	+8,325	New	+$999K	0.3%	48

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

PVG Asset Management's IBB Position: Q3 2024 in Review

PVG Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 3,022 shares — an estimated $415K sold.

PVG Asset Management first reported a position in IBB in Q3 2015 and held it in 9 quarters. The position peaked at $1.29M in Q1 2018. 895 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

PVG Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
PVG Asset Management sold 3,022 iShares Biotechnology ETF shares in Q3 2024, an estimated $415K.
PVG Asset Management first reported a position in iShares Biotechnology ETF in Q3 2015 and held it in 9 quarters.
PVG Asset Management's iShares Biotechnology ETF position peaked at $1.29M in Q1 2018.
895 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on PVG Asset Management's 13F filing for Q3 2024, filed 25 Nov 2024.